Stocktoria
IONIS PHARMACEUTICALS INC IONS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1991-05-17
IONIS PHARMACEUTICALS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -40.4% | -67.4% | -44.9% | -69.8% | -3.7% |
| Net margin | -40.4% | -64.4% | -46.5% | -45.9% | -3.5% |
| FCF margin | -33.9% | -77.5% | -42.1% | -49.4% | 2.3% |
| Return on assets | -10.8% | -15.1% | -12.3% | -10.6% | -1.1% |
| Return on equity | -78.0% | -77.1% | -94.7% | -47.1% | -3.7% |
| Debt / equity | 3.71× | 2.13× | 3.38× | 2.08× | — |
| Current ratio | 3.83 | 8.47 | 5.90 | 7.07 | 9.75 |
| Revenue growth | 33.8% | -10.5% | 34.1% | -27.5% | 11.1% |
Source: SEC EDGAR filings · CIK 0000874015 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.